AI checks found a distorted shadow on the guard's uniform and blurry name tags, signs of possible AI-generated visuals ...
IRX-101 targets a significant need for millions of patients facing vision loss and has the potential to improve the standard ...
Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today ...
A 76-year-old man presented with a 3-week history of binocular vertical diplopia.He denied change in vision, pain with eye ...
Biocon Limited (BSE: 532523; NSE: BIOCON), an innovation‑led global biopharmaceutical company, today announced the publication of two important clinical studies supporting the effectiveness of ...
Andrew G. Lee, MD, and Drew Carey, MD, discuss findings from a retrospective study examining ischemic stroke risk in patients with non-arteritic anterior ischemic optic neuropathy and the implications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results